Minireviews
Copyright ©The Author(s) 2016.
World J Transplant. Sep 24, 2016; 6(3): 564-572
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.564
Figure 1
Figure 1 The Kaplan-Meier graft survival for the presence of performed donor-specific antibodies before transplant and newly formed (de novo) donor-specific antibodies after transplant. Patients with preformed donor-specific antibodies (DSA) had significantly lower graft survival than those without preformed DSA. The graft survival was markedly worse in patients with de novo DSA or persistent DSA.